par Torres, David ;Köhler, Arnaud ;Delbauve, Sandrine ;Caminschi, Irina;Lahoud, Mireille;Shortman, Ken;Flamand, Véronique
Référence P L o S Pathogens, 12, 4, e1005561
Publication Publié, 2016-04
Référence P L o S Pathogens, 12, 4, e1005561
Publication Publié, 2016-04
Article révisé par les pairs
Résumé : | Infection by Listeria monocytogenes (Lm) causes serious sepsis and meningitis leading to mortality in neonates. This work explored the ability of CD11chighlineage DCs to induce CD8+T-cell immune protection against Lm in mice before 7 days of life, a period symbolized by the absence of murine IL-12p70-producing CD11chighCD8α+dendritic cells (DCs). We characterized a dominant functional Batf3-dependent precursor of CD11chighDCs that is Clec9A+CD205+CD24+but CD8α-at 3 days of life. After Lm-OVA infection, these pre-DCs that cross-present Ag display the unique ability to produce high levels of IL-12p40 (not IL-12p70 nor IL-23), which enhances OVA-specific CD8+T cell response, and regulatory IL-10 that limits OVA-specific CD8+T cell response. Targeting these neonatal pre-DCs for the first time with a single treatment of anti-Clec9A-OVA antibody in combination with a DC activating agent such as poly(I:C) increased the protection against later exposure to the Lm-OVA strain. Poly(I:C) was shown to induce IL-12p40 production, but not IL-10 by neonatal pre-DCs. In conclusion, we identified a new biologically active precursor of Clec9A+CD8α-DCs, endowed with regulatory properties in early life that represents a valuable target to augment memory responses to vaccines. |